Who owns ALIGOS THERAPEUTICS INC?
- Ticker: ALGS
- CUSIP Number: 01626l204
Tip: Access positions for across all investors
Analyze quarterly positions in Aligos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aligos Therapeutics stock
Who bought or sold ALIGOS THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deep Track Capital | 444k | $3.3M | 0% | Mar 2026 |
|
| Alyeska Investment Group | 412k | $3.1M | 0% | Mar 2026 |
|
| Sio Capital Management | 336k | $3.1M | 0% | Dec 2025 |
|
| Marshall Wace | 269k | $2.5M | 100% | Dec 2025 |
|
| Bank of America Corporation | 230k | $1.7M | 100% | Mar 2026 |
|
| Vanguard Group | 200k | $1.9M | 17% | Dec 2025 |
|
| Vanguard Capital Management | 178k | $1.3M | 100% | Mar 2026 |
|
| Woodline Partners | 177k | $1.3M | -39% | Mar 2026 |
|
| SummitTX Capital | 149k | $1.1M | 7% | Mar 2026 |
|
| Renaissance Technologies | 85k | $796k | 55% | Dec 2025 |
|
| Baker Bros. Advisors | 83k | $617k | 0% | Mar 2026 |
|
| Hillhouse Capital Advisors | 76k | $567k | 0% | Mar 2026 |
|
| Verition Fund Management | 71k | $664k | 100% | Dec 2025 |
|
| Citadel Advisors | 54k | $404k | 5% | Mar 2026 |
|
| LPL Financial | 52k | $383k | -22% | Mar 2026 |
|
| Geode Capital Management | 50k | $372k | 5% | Mar 2026 |
|
| UBS Group | 37k | $275k | 10082% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 28k | $211k | 100% | Mar 2026 |
|
| Two Sigma Investments | 23k | $172k | -71% | Mar 2026 |
|
| XTX Topco | 23k | $215k | 100% | Dec 2025 |
|
| BlackRock | 13k | $97k | 0% | Mar 2026 |
|
| D. E. Shaw & Co | 11k | $82k | 100% | Mar 2026 |
|
| Rockefeller Capital Management | 10k | $74k | 0% | Mar 2026 |
|
| FMR | 5.0k | $46k | 100% | Dec 2025 |
|
| Golden State Wealth Management | 2.7k | $20k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 2.1k | $16k | 0% | Mar 2026 |
|
| Federation des caisses Desjardins du Quebec | 950.00 | $7.1k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 936.00 | $7.0k | 100% | Mar 2026 |
|
| Wells Fargo & Company | 700.00 | $5.2k | -53% | Mar 2026 |
|
| Global Retirement Partners | 400.00 | $3.7k | -50% | Dec 2025 |
|
| Morgan Stanley | 218.00 | $1.6k | -91% | Mar 2026 |
|
| Tower Research Capital | 39.00 | $363.000300 | -91% | Dec 2025 |
|
| SBI Securities | 26.00 | $193.000600 | 0% | Mar 2026 |
|
| Zrc Wealth Management | 4.00 | $30.000000 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 3.00 | $21.999900 | 0% | Mar 2026 |
|
Who sold out of Aligos Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Adage Capital Partners GP | Sep 2025 | 140k | $1.4M |
| Jane Street | Dec 2025 | 24k | $226k |
| Quest Partners | Dec 2025 | 14k | $129k |
| Two Sigma Advisers | Dec 2025 | 13k | $121k |
| DRW Holdings | Dec 2025 | 12k | $111k |
| Hrt Financial | Dec 2025 | 11k | $106k |
| Susquehanna International | Sep 2025 | 10k | $99k |
| NorthCrest Asset Manangement | Dec 2025 | 10k | $84k |
| Jpmorgan Chase & Co | Sep 2025 | 708.00 | $6.9k |
| White Bay PT | Dec 2025 | 500.00 | $4.7k |
| Barclays | Sep 2025 | 15.00 | $147.000000 |